Casdin Capital, Llc - Net Worth and Insider Trading

Casdin Capital, Llc Net Worth

The estimated net worth of Casdin Capital, Llc is at least $97 Million dollars as of 2024-05-16. Casdin Capital, Llc is the Director, 10% Owner of GeneDx Holdings Corp and owns about 3,522,697 shares of GeneDx Holdings Corp (WGS) stock worth over $81 Million. Casdin Capital, Llc is the Director of 2seventy bio Inc and owns about 1,976,600 shares of 2seventy bio Inc (TSVT) stock worth over $10 Million. Casdin Capital, Llc is also the 10% Owner of Generation Bio Co and owns about 1,611,215 shares of Generation Bio Co (GBIO) stock worth over $6 Million. Details can be seen in Casdin Capital, Llc's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Casdin Capital, Llc has not made any transactions after 2024-05-13 and currently still holds the listed stock(s).

Transaction Summary of Casdin Capital, Llc

To

Casdin Capital, Llc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Casdin Capital, Llc owns 9 companies in total, including BioLife Solutions Inc (BLFS) , Generation Bio Co (GBIO) , and Fulcrum Therapeutics Inc (FULC) among others .

Click here to see the complete history of Casdin Capital, Llc’s form 4 insider trades.

Insider Ownership Summary of Casdin Capital, Llc

Ticker Comapny Transaction Date Type of Owner
BLFS BioLife Solutions Inc 2018-08-10 10 percent owner
GBIO Generation Bio Co 2020-06-16 10 percent owner
FULC Fulcrum Therapeutics Inc 2019-07-17 10 percent owner
2018-07-23 10 percent owner
2023-05-17 director & 10 percent owner
2021-07-29 10 percent owner
2021-07-21 director & 10 percent owner
2022-11-17 director
2024-03-05 director & 10 percent owner

Casdin Capital, Llc Latest Holdings Summary

Casdin Capital, Llc currently owns a total of 3 stocks. Among these stocks, Casdin Capital, Llc owns 3,522,697 shares of GeneDx Holdings Corp (WGS) as of May 13, 2024, with a value of $81 Million and a weighting of 83.61%. Casdin Capital, Llc owns 1,976,600 shares of 2seventy bio Inc (TSVT) as of March 25, 2024, with a value of $10 Million and a weighting of 9.95%. Casdin Capital, Llc also owns 1,611,215 shares of Generation Bio Co (GBIO) as of June 16, 2020, with a value of $6 Million and a weighting of 6.43%.

Latest Holdings of Casdin Capital, Llc

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
WGS GeneDx Holdings Corp 2024-05-13 3,522,697 23.01 81,039,644
TSVT 2seventy bio Inc 2024-03-25 1,976,600 4.88 9,645,808
GBIO Generation Bio Co 2020-06-16 1,611,215 3.87 6,235,402

Holding Weightings of Casdin Capital, Llc


Casdin Capital, Llc Form 4 Trading Tracker

According to the SEC Form 4 filings, Casdin Capital, Llc has made a total of 2 transactions in GeneDx Holdings Corp (WGS) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in GeneDx Holdings Corp is the acquisition of 50,000 shares on May 13, 2024, which cost Casdin Capital, Llc around $1 Million.

According to the SEC Form 4 filings, Casdin Capital, Llc has made a total of 1 transactions in 2seventy bio Inc (TSVT) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in 2seventy bio Inc is the acquisition of 777,377 shares on March 25, 2024, which cost Casdin Capital, Llc around $4 Million.

According to the SEC Form 4 filings, Casdin Capital, Llc has made a total of 1 transactions in Generation Bio Co (GBIO) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Generation Bio Co is the acquisition of 650,000 shares on June 16, 2020, which cost Casdin Capital, Llc around $12 Million.

Insider Trading History of Casdin Capital, Llc

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Casdin Capital, Llc Trading Performance

GuruFocus tracks the stock performance after each of Casdin Capital, Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Casdin Capital, Llc is 48.56%. GuruFocus also compares Casdin Capital, Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Casdin Capital, Llc within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Casdin Capital, Llc's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Casdin Capital, Llc

Average Return

Average return per transaction

Outperforming Transactions

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -1.15
Relative Return to S&P 500(%) -1.86

Casdin Capital, Llc Ownership Network

Ownership Network List of Casdin Capital, Llc

No Data

Ownership Network Relation of Casdin Capital, Llc


Casdin Capital, Llc Owned Company Details

What does BioLife Solutions Inc do?

Who are the key executives at BioLife Solutions Inc?

Casdin Capital, Llc is the 10 percent owner of BioLife Solutions Inc. Other key executives at BioLife Solutions Inc include VP & Global Human Resources Sarah Aebersold , Chief Tech. Officer & Sr. VP Aby J. Mathew , and Vice President & Marketing Todd Berard .

BioLife Solutions Inc (BLFS) Insider Trades Summary

Over the past 18 months, Casdin Capital, Llc made no insider transaction in BioLife Solutions Inc (BLFS). Other recent insider transactions involving BioLife Solutions Inc (BLFS) include a net sale of 162,179 shares made by Aby J. Mathew , a net sale of 48,109 shares made by Todd Berard , and a net sale of 16,023 shares made by Karen A. Foster .

In summary, during the past 3 months, insiders sold 73,911 shares of BioLife Solutions Inc (BLFS) in total and bought 0 shares, with a net sale of 73,911 shares. During the past 18 months, 504,114 shares of BioLife Solutions Inc (BLFS) were sold and 1,135,630 shares were bought by its insiders, resulting in a net purchase of 631,516 shares.

BioLife Solutions Inc (BLFS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

BioLife Solutions Inc Insider Transactions

No Available Data

Casdin Capital, Llc Mailing Address

Above is the net worth, insider trading, and ownership report for Casdin Capital, Llc. You might contact Casdin Capital, Llc via mailing address: 1350 Avenue Of The Americas, Suite 2600, New York Ny 10019.

Discussions on Casdin Capital, Llc

No discussions yet.